HRL
39
9
NDAQ
59
-4
TGT
50
-2
VTR
50
-5
FOX
59
2
LNC
43
-2
EXC
53
12
SYK
71
-2
STI
21
-10
IRM
39
-3
LLY
37
-7
TSN
50
2
DIS
68
6
ZTS
47
-2
EL
20
2
FE
41
-3
EXPD
48
5
AVB
64
-3
CTAS
56
-8
GIS
26
-3
HRL
39
9
NDAQ
59
-4
TGT
50
-2
VTR
50
-5
FOX
59
2
LNC
43
-2
EXC
53
12
SYK
71
-2
STI
21
-10
IRM
39
-3
LLY
37
-7
TSN
50
2
DIS
68
6
ZTS
47
-2
EL
20
2
FE
41
-3
EXPD
48
5
AVB
64
-3
CTAS
56
-8
GIS
26
-3
Financhill
Back

Lifecore Biomedical 10K Form

Sell
39

LFCR
Lifecore Biomedical

Last Price:
6.43
Seasonality Move:
0.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFCR News And Ratings

See the #1 stock for the next 7 days that we like better than LFCR

LFCR Financial Statistics

Sales & Book Value

Annual Sales: $128.26M
Cash Flow: $-4.04M
Price / Cash Flow: 0
Annual Sales: $-0.13
Price / Book: 0

Profitability

EPS (TTM): 0.05000
Net Income (TTM): $6.54M
Gross Margin: $41.85M
Return on Equity: 252.9%
Return on Assets: 2.64%

Lifecore Biomedical Earnings Forecast

Key Lifecore Biomedical Financial Ratios

  • The Gross Profit Margin over the past 29 years for LFCR is 32.63%.
  • The Selling, General & Administrative Expenses for LFCR have been equal to 31.55% of Gross Profit Margin.
  • The Research & Development expenses have been 6.69% of Revenue.
  • The Interest Expense is 150.59% of Operating Income.
  • The Net Earning history of LFCR is 9.37% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Lifecore Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LFCR
Website: lifecore.com

Debt

Debt-to-Equity Ratio: -32.48
Current Ratio: 1.83
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 20.88
Forward P/E Ratio: 0

LFCR Technical Analysis vs Fundamental Analysis

Sell
39
Lifecore Biomedical (LFCR) is a Sell

Is Lifecore Biomedical a Buy or a Sell?